Correlation Engine 2.0
Clear Search sequence regions


  • adult (2)
  • cohort (2)
  • diagnosis (2)
  • DNMT3A (1)
  • helper cells (3)
  • humans (1)
  • IDH2 (1)
  • patients (11)
  • steroid (4)
  • t cell (1)
  • t cell lymphomas (3)
  • TET2 (1)
  • Sizes of these terms reflect their relevance to your search.

    Follicular helper T-cell lymphomas (TFHL) have an aggressive course with a poor outcome. European and US guidelines recommend anthracycline-based chemotherapy as a first-line treatment, but the 5-year overall survival rate is still approximately 30%. We describe here the features of a cohort of TFHL patients who experienced prolonged survival despite the absence of specific treatment or the initiation of steroid-based therapy. In our study, we describe 15 adult patients who suffered from TFHL and had not received intensive chemotherapy at diagnosis for any reason. Biopsies of these cases were centrally reviewed, and the mutational pattern was determined using next-generation sequencing. These 15 patients had the classic clinical, biological and pathological features of TFHL, angioimmunoblastic-type. TET2 mutations were found in 83% of patients; RHOA G17V, IDH2 R172 and DNMT3A mutations were found in 67%, 42% and 33% of the patients, respectively. Among the 15 patients, 8 did not receive any treatment, and 7 received steroid-based treatment. Ten patients had progression (5 in each group). Four patients died (3 of them from the progression of their lymphoma). The median follow-up in our cohort was 53 months. The 5-year OS was 66%, 100% for untreated patients and 29% for the others. In those 2 groups, the median time to treatment initiation was 22 months from diagnosis. We described a series of 15 well-characterized TFHL patients with an indolent outcome, suggesting that a watch-and-wait approach can be proposed in selected patients. Identifying factors predicting such evolution is warranted. Copyright © 2023 Elsevier Ltd. All rights reserved.

    Citation

    Ondine Messéant, Fanny Drieux, Nouhoum Sako, Virginie Fataccioli, Vincent Camus, Cyrielle Robe, Roch Houot, Patrick Tas, Francisco Llamas-Gutierrez, Claire Lamaison, Julie Abraham, Manuela Delage-Corre, Soraya Benguerfi, Jean-Baptiste Bossard, Philippe Gaulard, François Lemonnier. Clinical and histological study of follicular helper T-cell lymphomas with indolent evolution. European journal of cancer (Oxford, England : 1990). 2024 Jan;197:113479

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 38128263

    View Full Text